Sequential Time to Positivity as a Prognostic Indicator in Staphylococcus aureus Bacteremia

被引:1
|
作者
Comba, Isin Y. [1 ,3 ]
Go, John Raymond [1 ]
Vaillant, James [1 ]
O'Horo, John C. [1 ]
Stevens, Ryan W. [2 ]
Palraj, Raj [1 ]
Abu Saleh, Omar [1 ,3 ]
机构
[1] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, Dept Med, Rochester, MN USA
[2] Mayo Clin, Dept Pharm, Rochester, MN USA
[3] Mayo Clin, Div Publ Hlth Infect Dis & Occupat Med, 200 First St SW, Rochester, MN 55905 USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2024年 / 11卷 / 04期
关键词
bacteremia; blood cultures; infective endocaditis; Staphylococcus aureus; time to positivity; BLOOD CULTURES; PREDICTOR; MORTALITY; INFECTIONS; MANAGEMENT; ADULTS;
D O I
10.1093/ofid/ofae173
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: We aimed to determine the factors associated with sequential blood culture time to positivity (STTP) and validate the previously defined time to positivity (TTP) ratio threshold of 1.5 in predicting adverse disease outcomes and mortality of Staphylococcus aureus bacteremia (SAB). Methods: We conducted an observational study of adult patients with SAB. The TTP ratio was calculated by dividing the TTP of the second blood culture by that of the first. Results: Of 186 patients, 69 (37%) were female, with a mean age of 63.6 years. Median TTP was 12 hours (interquartile range [IQR], 10-15 hours) from the initial and 21 hours (17-29) from sequential blood cultures. Methicillin-resistant S aureus (MRSA)-infected patients had significantly shorter STTPs (P < .001) and lower TTP ratios (P < .001) compared to patients with methicillin-susceptible S aureus (MSSA). A significant correlation between initial and STTP was observed in patients with MRSA (r = 0.42, P = .002) but not in those with MSSA. A higher rate of native valve endocarditis (NVE) significantly correlated with a TTP ratio of <= 1.5 (odds ratio, 2.65 [95% confidence interval, 1.3-5.6]; P = .01). The subgroup having an initial TTP <12 hours combined with a TTP ratio <= 1.5 showed the highest prevalence of NVE. Conclusions: The STTP varies based on methicillin susceptibility of S aureus isolate. This study suggests a potential clinical utility of the STTP to identify patients at a higher risk of NVE. However, prospective studies are required to validate these findings.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Aortitis and Recurrent Staphylococcus aureus Bacteremia
    Coutinho, Andreia
    Monteiro, Ines De Albuquerque
    Festa, Sofia
    Teixeira, Sofia
    Iglesias, Violeta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [42] Staphylococcus aureus bacteremia and the skip phenomenon
    Raj Palraj
    M. Rizwan Sohail
    Larry M. Baddour
    Infection, 2020, 48 : 653 - 654
  • [43] Sulfapyridine in the treatment of Staphylococcus aureus bacteremia
    Goldberg, SL
    Sachs, A
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1939, 113 : 1639 - 1641
  • [44] Prostate Abscesses and Staphylococcus aureus Bacteremia
    Schattner, Ami
    Finn, Talya
    Glick, Yair
    Dubin, Ina
    AMERICAN JOURNAL OF MEDICINE, 2018, 131 (10): : E417 - E418
  • [45] Management of Staphylococcus aureus bacteremia in adults
    Bai, Anthony D.
    Morris, Andrew M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (35) : E967 - E967
  • [46] Methicillin resistant Staphylococcus aureus bacteremia
    De Araujo Otero, Stephanie
    Lagrutta, Mariana
    Negro Marquinez, Liliana
    Paro-Di, Roberto
    Perez, Jorgelina
    Falco, Gabriela
    Greca, Alcides
    REVISTA MEDICA DE ROSARIO, 2019, 85 (03): : 113 - 125
  • [47] Clinical Subphenotypes of Staphylococcus aureus Bacteremia
    Swets, Maaike C.
    Bakk, Zsuzsa
    Westgeest, Annette C.
    Berry, Karla
    Cooper, George
    Sim, Wynne
    Lee, Rui Shian
    Gan, Tze Yi
    Donlon, William
    Besu, Antonia
    Heppenstall, Emily
    Tysall, Luke
    Dewar, Simon
    de Boer, Mark
    Fowler Jr, Vance G.
    Dockrell, David H.
    Thwaites, Guy E.
    Pujol, Miquel
    Pallares, Natalia
    Tebe, Cristian
    Carratala, Jordi
    Szubert, Alexander
    Groeneveld, Geert H.
    Russell, Clark D.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (05) : 1153 - 1161
  • [48] Ceftobiprole for Staphylococcus aureus Bacteremia REPLY
    Holland, Thomas L.
    Engelhardt, Marc
    Fowler, Vance G., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (26): : 2499 - 2499
  • [49] NEGLECTED GUIDELINES OF STAPHYLOCOCCUS AUREUS BACTEREMIA
    Dutta, A.
    Goldman, J.
    Cheriyath, P.
    Wert, Y.
    CARDIOLOGY, 2015, 131 : 66 - 66
  • [50] Staphylococcus aureus bacteremia: A continuing challenge
    Singla, Nidhi
    Bansal, Neha
    Chander, Jagdish
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 4 (01) : 51 - U68